Life ScienceCompany
Where is CoTherix headquartered?
CoTherix is headquartered in South San Francisco, California.
What sector is CoTherix in?
CoTherix is a life science company.
When was CoTherix founded?
CoTherix was founded in 2000.
CoTherix is headquartered in South San Francisco, California.
CoTherix is a life science company.
CoTherix was founded in 2000.
5000 Shoreline Court, Suite 101,
South San Francisco, California
94080
United States,
(650) 808-6500
CoTherix, Inc. is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the potential treatment of cardiovascular disease. CoTherix, Inc. licensed the exclusive U.S. rights to Ventavis® from Schering AG, which currently markets Ventavis® in Europe and Australia. In June 2006, CoTherix, Inc., licensed exclusive rights to develop and commercialize oral and inhaled formulations of Fasudil, a rho-kinase inhibitor, for the treatment of PAH and stable angina in North America and Europe from Asahi Kasei Pharma Corporation.
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.